Trial of THEO-260 in Ovarian Cancer Patients
Trial of THEO-260 in Ovarian Cancer Patients
Recruiting · NCT06618235 · Registry updated 2026-04-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Trial of THEO-260 in Ovarian Cancer Patients | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder | Recruiting | Phase 1 / Phase 2 | 2026-04-14 | NCT06618235 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Theolytics Limited | 2 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centro Integral Oncológico Clara Campal (CIOCC) Hospital | Madrid | Spain | 1 |
| Imperial College Healthcare NHS Trust, Hammersmith Hospital | London | United Kingdom | 1 |
| Oxford University Hospitals NHS Foundation Trust, Churchill Hospital | Oxford | United Kingdom | 1 |
| The Beatson West of Scotland Cancer Centre | Glasgow | United Kingdom | 1 |